Stable rowing simulator
Devicea standard stable/fixed rowing simulator
NCT Number: NCT03253900
Rowing simulators are frequently used by rowers, when on-water training is impossible or limited. While such devices are highly valuable to maintain rowers' fitness, a concern was raised about extensive simulator usage. It was postulated that it could lead to technique alterations due to different biomechanical properties compared to on-water rowing. Slide-based rowing simulators were designed to better simulate on-water conditions.
The main aim of the study was to compare the differences in various kinematic and kinetic parameters during a short (20 s) all-out rowing bout and during a 2000-m simulated race, to get a better insight into how different rowing simulator designs affect biomechanics of rowing.
Three different rowing simulators were used in this study: (1) a standard stable/fixed rowing simulator, (2) a slides based rowing simulator, i.e. horizontal plane unstable, and (3) a tilt board based rowing simulator; i.e. frontal plane unstable.
The investigators hypothesised that rowing on different simulators will elicit different biomechanics, including forces, power output, arm and seat movement velocity and amplitude.
Each of the participants completed the tests in all three interventions on separate sessions; random order of interventions. The three sessions took place 7-10 days apart. During each session, the participants completed the all-out 20-s trial first, then the simulated 2000-m race. The aforementioned biomechanical parameters were tracked throughout the trials to be compared between interventions later.
Looking for future studies?
Notify Me15 year–30 year
Male
Interventional
Not applicable
The measurements will take place at University of Primorska (Koper, Slovenia) and the subjects will be recruited in close collaboration with Rowing Club Piran. Crossover study design will be used. Each participant will be asked to come for three visits that will be scheduled 7-10 days apart. Prior to measurements onset, the whole protocol will be explained to the participant.
Measurement procedure:
After both trials, blood lactate will be measured. Blood sample will be taken at the the earlobe by a qualified medical personnel.
Maximal performance test: The participant will perform a 20-s interval with maximal effort. The main aim of the measurement is to record the maximal exerted force and power. The custom adapted device (Concept 2 Rowing Simulator) records the positions (seat and handle) and force (legs push and handle pull), which enables for further calculations of segmental and common kinematics and dynamics parameters.
Race simulation: the participant will complete the 2000-m simulated race and will be instructed to aim for the best results. The same measurements as in the maximal performance test will be performed. Wireless heart rate monitor will be used to record the heart frequency throughout the trial.
Equipment:
The custom adapted rowing simulator (Concept 2) allows for the measurements of stoke forces and consequently power outputs, seat and handle velocity, and seat and handle amplitudes. Signals will be transferred to central unit, amplified and converted, and stored on a personal computer.
The interventions (i.e. the studied rowing conditions) will be as follows:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
a standard stable/fixed rowing simulator
a slides based rowing simulator, i.e. horizontal plane unstable
a tilt board based rowing simulator; i.e. frontal plane unstable
Time frame: Three sessions, with randomized order of ergometers (7-10 days apart)
Rowing biomechanics on different rowing simulators.
Time frame: At the onset of test, at the finish and at the three points in between (at 500, 1000 and 1500 meters of the simulated race) - ref. POM: sessions 7-10 days apart.
Change of the average velocity of arm movement through the rowing stroke.
Time frame: At the onset of test, at the finish and at the three points in between (at 500, 1000 and 1500 meters of the simulated race) - ref. POM: sessions 7-10 days apart.
Change of the average velocity of the seat movement through the rowing stroke.
Time frame: At the onset of test, at the finish and at the three points in between (at 500, 1000 and 1500 meters of the simulated race) - ref. POM: sessions 7-10 days apart.
Change of the average arm force through the rowing stroke.
Time frame: At the onset of test, at the finish and at the three points in between (at 500, 1000 and 1500 meters of the simulated race) - ref. POM: sessions 7-10 days apart.
Change of the average handle through the rowing stroke.
Time frame: At the onset of test, at the finish and at the three points in between (at 500, 1000 and 1500 meters of the simulated race) - ref. POM: sessions 7-10 days apart.
Change of the average leg force through the rowing stroke.
Time frame: At the onset of test, at the finish and at the three points in between (at 500, 1000 and 1500 meters of the simulated race) - ref. POM: sessions 7-10 days apart.
Change of the average amplitude of the seat movement through the rowing stroke.
Time frame: Before and immediately after the test, ref. POM: sessions 7-10 days apart. .
Change in blood lactate concentration
University of Primorska
Other
Changes of Biomechanical Parameters During Race Simulation Rowing - The Effect of (In)Stability of the Simulator
Acronym: RowBio
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsNCT06702423
Healthy
London, United Kingdom
View Trial DetailsNCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details